FIRST AMENDMENT OF EXCLUSIVE TECHNOLOGY OPTION AGREEMENTExclusive Technology Option Agreement • November 12th, 2009 • Omeros Corp • Pharmaceutical preparations • Moca
This amendment (this “Amendment”) serves to amend the Exclusive Technology Option Agreement dated September 4, 2008 between Omeros Corporation (“Omeros”), Patobios Limited (“Patobios”), Susan R. George, M.D., Brian F. O’Dowd, Ph.D. and U.S. Bank National Association (the “Agreement”) and is effective as of November 10, 2009. Except as expressly set forth below, capitalized terms used and not redefined in this Amendment have the same meanings given to them in the Agreement.
